Request a consultation Call: (310) 626-1312

Glioma Treatment Options at Atlas Institute in Los Angeles

At the Atlas Institute of Brain and Spine in Los Angeles, we specialize in advanced glioma treatment options tailored to each patient’s unique needs. Dr. Aaron Cohen-Gadol, renowned worldwide for performing complex neurosurgery, leads our team. Gliomas are a diverse group of tumors that arise from glial cells in the brain and spinal cord. They can be classified into low-grade and high-grade types, affecting patients in various ways. Our approach combines pioneering surgical techniques, including fluorescence-guided tumor resection, and comprehensive care, ensuring the best possible outcomes for patients facing this challenging diagnosis.

What Types of Gliomas Are Commonly Diagnosed?

Gliomas include several types based on their cellular origin and characteristics; two principal categories of gliomas are low-grade and high-grade gliomas. Low-grade gliomas (Grades I and II) are slow-growing and generally more benign, while high-grade gliomas, particularly glioblastomas, are aggressive and invasive, requiring immediate and tailored treatment strategies. Advanced radiation techniques like intensity-modulated radiotherapy (IMRT) and stereotactic radiosurgery (SRS) offer precise tumor targeting, minimizing damage to healthy brain tissue.

How Does Glioma Grading Impact Treatment Choices?

The World Health Organization classifies gliomas based on their aggressiveness. Grade I tumors are associated with favorable prognoses and often have high survival rates, while Grade IV tumors, like glioblastomas, present significant treatment challenges. The grading of the tumor significantly influences the treatment decisions, as higher-grade gliomas typically necessitate a multi-faceted approach that includes surgery, radiation, and chemotherapy. For example, the RTOG 9802 study showed that adding adjuvant PCV chemotherapy to radiotherapy significantly improved overall survival in patients with high-risk low-grade gliomas.

No description metadata found
No description metadata found

What Are the Key Symptoms of Gliomas?

Patients with gliomas may experience a range of symptoms that can vary widely based on tumor size and location. Common symptoms include:

  • Persistent headaches
  • Nausea and vomiting
  • Seizures
  • Changes in personality or cognition
  • Weakness or numbness in parts of the body
  • Difficulties with language or communication

How Are Gliomas Diagnosed With Imaging and Biopsies?

The diagnostic process for gliomas typically begins with imaging studies, especially Magnetic Resonance Imaging (MRI), which can reveal tumor presence and extent. In some cases, a biopsy is performed to obtain tissue samples for histological analysis, allowing for accurate diagnosis and grading. Genetic testing may also be conducted to understand the tumor’s behavior better and inform treatment strategies. The UCLA Brain Tumor Center provides comprehensive care for all types and grades of gliomas, utilizing advanced diagnostic and treatment services.

What Surgical Approaches Are Taken for Glioma Treatment?

Surgery is often the first line of defense against gliomas. At the Atlas Institute, we employ advanced techniques such as fluorescence-guided brain tumor resection, which assists in maximizing tumor removal while preserving healthy brain tissue. The surgical approach varies based on tumor location, size, and grade, and includes:

  • Craniotomy for tumor access and removal
  • Debulking procedures for larger gliomas

How Is Radiation Therapy Utilized in Glioma Management?

Post-surgical radiation therapy is a critical component in managing high-grade gliomas. Techniques such as Intensity-Modulated Radiation Therapy (IMRT) allow for targeted delivery of radiation, minimizing damage to surrounding healthy tissue. This treatment aims to control tumor growth and improve patient outcomes while requiring regular monitoring through follow-up MRIs to check for recurrence.

What Advanced Chemotherapy Options Are Available for Gliomas?

Chemotherapy is often employed alongside radiation post-surgery, especially for aggressive gliomas. Medications such as temozolomide and bevacizumab are used to inhibit tumor growth and manage glioblastomas effectively. Ongoing clinical trials are also exploring novel therapies like immunotherapy and gene therapy to enhance treatment efficacy. The combination of trametinib (MEK inhibitor) and dabrafenib (BRAF inhibitor) has been FDA-approved for treating pediatric patients aged 1 year and older with low-grade gliomas harboring the BRAF V600E mutation.

No description metadata found

Frequently Asked Questions About Gliomas

Dr. Aaron Cohen-Gadol with patient

The Atlas Institute Advantage for Glioma Patients

Choosing the Atlas Institute means opting for a facility led by Dr. Aaron Cohen Gadol, a globally recognized neurosurgeon with:

  • Over 7,500 complex brain surgeries performed
  • A dedication to individualized treatment planning
  • Access to cutting-edge technology and techniques
  • A compassionate care team committed to your journey
  • Ongoing mentoring of neurosurgeons, fellows, and surgical trainees
Contact Us

Schedule Your Consultation Today

If you are facing a glioma diagnosis, seek guidance from our team at the Atlas Institute in Los Angeles. Led by Dr. Aaron Cohen Gadol, a prominent figure in neurosurgery and founder of The Neurosurgical Atlas, we offer comprehensive care tailored to your specific needs. Reach out to schedule your consultation today to explore your treatment options.

Skip footer